Localized Changes in Dentate Nucleus Shape and Magnetic Susceptibility in Friedreich Ataxia.
biomarker
cerebellum
magnetic resonance imaging
Journal
Movement disorders : official journal of the Movement Disorder Society
ISSN: 1531-8257
Titre abrégé: Mov Disord
Pays: United States
ID NLM: 8610688
Informations de publication
Date de publication:
22 Apr 2024
22 Apr 2024
Historique:
revised:
07
03
2024
received:
13
11
2023
accepted:
01
04
2024
medline:
22
4
2024
pubmed:
22
4
2024
entrez:
22
4
2024
Statut:
aheadofprint
Résumé
The dentate nuclei of the cerebellum are key sites of neuropathology in Friedreich ataxia (FRDA). Reduced dentate nucleus volume and increased mean magnetic susceptibility, a proxy of iron concentration, have been reported by magnetic resonance imaging studies in people with FRDA. Here, we investigate whether these changes are regionally heterogeneous. Quantitative susceptibility mapping data were acquired from 49 people with FRDA and 46 healthy controls. The dentate nuclei were manually segmented and analyzed using three dimensional vertex-based shape modeling and voxel-based assessments to identify regional changes in morphometry and susceptibility, respectively. Individuals with FRDA, relative to healthy controls, showed significant bilateral surface contraction most strongly at the rostral and caudal boundaries of the dentate nuclei. The magnitude of this surface contraction correlated with disease duration, and to a lesser extent, ataxia severity. Significantly greater susceptibility was also evident in the FRDA cohort relative to controls, but was instead localized to bilateral dorsomedial areas, and also correlated with disease duration and ataxia severity. Changes in the structure of the dentate nuclei in FRDA are not spatially uniform. Atrophy is greatest in areas with high gray matter density, whereas increases in susceptibility-reflecting iron concentration, demyelination, and/or gliosis-predominate in the medial white matter. These findings converge with established histological reports and indicate that regional measures of dentate nucleus substructure are more sensitive measures of disease expression than full-structure averages. Biomarker development and therapeutic strategies that directly target the dentate nuclei, such as gene therapies, may be optimized by targeting these areas of maximal pathology. © 2024 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
Sections du résumé
BACKGROUND
BACKGROUND
The dentate nuclei of the cerebellum are key sites of neuropathology in Friedreich ataxia (FRDA). Reduced dentate nucleus volume and increased mean magnetic susceptibility, a proxy of iron concentration, have been reported by magnetic resonance imaging studies in people with FRDA. Here, we investigate whether these changes are regionally heterogeneous.
METHODS
METHODS
Quantitative susceptibility mapping data were acquired from 49 people with FRDA and 46 healthy controls. The dentate nuclei were manually segmented and analyzed using three dimensional vertex-based shape modeling and voxel-based assessments to identify regional changes in morphometry and susceptibility, respectively.
RESULTS
RESULTS
Individuals with FRDA, relative to healthy controls, showed significant bilateral surface contraction most strongly at the rostral and caudal boundaries of the dentate nuclei. The magnitude of this surface contraction correlated with disease duration, and to a lesser extent, ataxia severity. Significantly greater susceptibility was also evident in the FRDA cohort relative to controls, but was instead localized to bilateral dorsomedial areas, and also correlated with disease duration and ataxia severity.
CONCLUSIONS
CONCLUSIONS
Changes in the structure of the dentate nuclei in FRDA are not spatially uniform. Atrophy is greatest in areas with high gray matter density, whereas increases in susceptibility-reflecting iron concentration, demyelination, and/or gliosis-predominate in the medial white matter. These findings converge with established histological reports and indicate that regional measures of dentate nucleus substructure are more sensitive measures of disease expression than full-structure averages. Biomarker development and therapeutic strategies that directly target the dentate nuclei, such as gene therapies, may be optimized by targeting these areas of maximal pathology. © 2024 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Friedreich Ataxia Research Association (Australia)
Organisme : National Health and Medical Research Council
ID : Fellowship 1106533
Organisme : National Health and Medical Research Council
ID : Ideas Grant 1184403
Organisme : National Health and Medical Research Council
ID : Project Grant 1046037
Organisme : Friedreich Ataxia Research Alliance (USA)
Informations de copyright
© 2024 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
Références
Harding IH, Lynch DR, Koeppen AH, Pandolfo M. Central nervous system therapeutic targets in Friedreich ataxia. Hum Gene Ther 2020;31(23–24):1226–1236.
Delatycki MB, Bidichandani SI. Friedreich ataxia pathogenesis and implications for therapies. Neurobiol Dis 2019;132:104606.
Koeppen AH, Davis AN, Morral JA. The cerebellar component of Friedreich's ataxia. Acta Neuropathol 2011;122(3):323–330.
Koeppen AH, Michael SC, Knutson MD, et al. The dentate nucleus in Friedreich's ataxia: the role of iron‐responsive proteins. Acta Neuropathol 2007;114(2):163–173.
Koeppen AH, Mazurkiewicz JE. Friedreich ataxia: neuropathology revised. J Neuropathol Exp Neurol 2013;72(2):78–90.
Bonilha da Silva C, Bergo FP, D'Abreu A, Cendes F, Lopes‐Cendes I, Franca MC Jr. Dentate nuclei T2 relaxometry is a reliable neuroimaging marker in Friedreich's ataxia. Eur J Neurol 2014;21(8):1131–1136.
Harding IH, Raniga P, Delatycki MB, et al. Tissue atrophy and elevated iron concentration in the extrapyramidal motor system in Friedreich ataxia: the IMAGE‐FRDA study. J Neurol Neurosurg Psychiatry 2016;87(11):1261–1263.
Ward PGD, Harding IH, Close TG, et al. Longitudinal evaluation of iron concentration and atrophy in the dentate nuclei in Friedreich ataxia. Mov Disord 2019;34(3):335–343.
Lindig T, Bender B, Kumar VJ, et al. Pattern of cerebellar atrophy in Friedreich's ataxia‐using the SUIT template. Cerebellum 2019;18(3):435–447.
Solbach K, Kraff O, Minnerop M, et al. Cerebellar pathology in Friedreich's ataxia: atrophied dentate nuclei with normal iron content. Neuroimage Clin 2014;6:93–99.
Stefanescu MR, Dohnalek M, Maderwald S, et al. Structural and functional MRI abnormalities of cerebellar cortex and nuclei in SCA3, SCA6 and Friedreich's ataxia. Brain 2015;138(Pt 5):1182–1197.
Harding IH, Chopra S, Arrigoni F, et al. Brain structure and degeneration staging in Friedreich ataxia: magnetic resonance imaging Volumetrics from the ENIGMA‐ataxia working group. Ann Neurol 2021;90(4):570–583.
Dimitrova A, Zeljko D, Schwarze F, et al. Probabilistic 3D MRI atlas of the human cerebellar dentate/interposed nuclei. Neuroimage 2006;30(1):12–25.
Kuper M, Dimitrova A, Thurling M, et al. Evidence for a motor and a non‐motor domain in the human dentate nucleus: an fMRI study. Neuroimage 2011;54(4):2612–2622.
Dum RP, Strick PL. An unfolded map of the cerebellar dentate nucleus and its projections to the cerebral cortex. J Neurophysiol 2003;89(1):634–639.
Guell X, D'Mello AM, Hubbard NA, et al. Functional territories of human dentate nucleus. Cereb Cortex 2020;30(4):2401–2417.
Kulkarni M, Kent JS, Park K, Guell X, Anteraper S. Resting‐state functional connectivity‐based parcellation of the human dentate nucleus: new findings and clinical relevance. Brain Struct Funct 2023;228(7):1799–1810.
Llorens JV, Soriano S, Calap‐Quintana P, Gonzalez‐Cabo P, Molto MD. The role of iron in Friedreich's ataxia: insights from studies in human tissues and cellular and animal models. Front Neurosci 2019;13:75.
Clark E, Johnson J, Dong YN, et al. Role of frataxin protein deficiency and metabolic dysfunction in Friedreich ataxia, an autosomal recessive mitochondrial disease. Neuronal. Signal 2018;2(4):NS20180060.
Alsina D, Purroy R, Ros J, Tamarit J. Iron in Friedreich ataxia: a central role in the pathophysiology or an epiphenomenon? Pharmaceuticals (Basel) 2018;11(3):89.
Boddaert N, Le Quan Sang KH, Rotig A, et al. Selective iron chelation in Friedreich ataxia: biologic and clinical implications. Blood 2007;110(1):401–408.
Straub S, Mangesius S, Emmerich J, et al. Toward quantitative neuroimaging biomarkers for Friedreich's ataxia at 7 tesla: susceptibility mapping, diffusion imaging, R(2) and R(1) relaxometry. J Neurosci Res 2020;98(11):2219–2231.
Koeppen AH, Ramirez RL, Yu D, et al. Friedreich's ataxia causes redistribution of iron, copper, and zinc in the dentate nucleus. Cerebellum 2012;11(4):845–860.
Deistung A, Schweser F, Reichenbach JR. Overview of quantitative susceptibility mapping. NMR Biomed 2017;30(4):e3569.
Langkammer C, Schweser F, Krebs N, et al. Quantitative susceptibility mapping (QSM) as a means to measure brain iron? A post mortem validation study. Neuroimage 2012;62(3):1593–1599.
Liu C, Li W, Johnson GA, Wu B. High‐field (9.4 T) MRI of brain dysmyelination by quantitative mapping of magnetic susceptibility. Neuroimage 2011;56(3):930–938.
Deistung A, Jaschke D, Draganova R, et al. Quantitative susceptibility mapping reveals alterations of dentate nuclei in common types of degenerative cerebellar ataxias. Brain Commun 2022;4(1):fcab306.
Turner LM, Jakabek D, Wilkes FA, et al. Striatal morphology correlates with frontostriatal electrophysiological motor processing in Huntington's disease: an IMAGE‐HD study. Brain Behav 2016;6(12):e00511.
Lindberg O, Walterfang M, Looi JC, et al. Hippocampal shape analysis in Alzheimer's disease and frontotemporal lobar degeneration subtypes. J Alzheimers Dis 2012;30(2):355–365.
Looi JC, Walterfang M, Styner M, et al. Shape analysis of the neostriatum in frontotemporal lobar degeneration, Alzheimer's disease, and controls. Neuroimage 2010;51(3):970–986.
Khan W, Corben LA, Bilal H, et al. Neuroinflammation in the cerebellum and brainstem in Friedreich ataxia: an [(18) F]‐FEMPA PET study. Mov Disord 2021;37(1):218–224.
Cocozza S, Costabile T, Pontillo G, et al. Cerebellum and cognition in Friedreich ataxia: a voxel‐based morphometry and volumetric MRI study. J Neurol 2020;267(2):350–358.
Cocozza S, Costabile T, Tedeschi E, et al. Cognitive and functional connectivity alterations in Friedreich's ataxia. Ann Clin Transl Neurol 2018;5(6):677–686.
Wu B, Li W, Guidon A, Liu C. Whole brain susceptibility mapping using compressed sensing. Magn Reson Med 2012;67(1):137–147.
Li W, Wu B, Liu C. Quantitative susceptibility mapping of human brain reflects spatial variation in tissue composition. Neuroimage 2011;55(4):1645–1656.
Smith SM. Fast robust automated brain extraction. Hum Brain Mapp 2002;17(3):143–155.
Koo TK, Li MY. A guideline of selecting and reporting Intraclass correlation coefficients for reliability research. J Chiropr Med 2016;15(2):155–163.
Styner M, Oguz I, Xu S, et al. Framework for the statistical shape analysis of brain structures using SPHARM‐PDM. Insight J 2006;1071:242–250.
Akhlaghi H, Corben L, Georgiou‐Karistianis N, et al. Superior cerebellar peduncle atrophy in Friedreich's ataxia correlates with disease symptoms. Cerebellum 2011;10(1):81–87.
Selvadurai LP, Corben LA, Delatycki MB, et al. Multiple mechanisms underpin cerebral and cerebellar white matter deficits in Friedreich ataxia: the IMAGE‐FRDA study. Hum Brain Mapp 2020;41(7):1920–1933.
Tellmann S, Bludau S, Eickhoff S, Mohlberg H, Minnerop M, Amunts K. Cytoarchitectonic mapping of the human brain cerebellar nuclei in stereotaxic space and delineation of their co‐activation patterns. Front Neuroanat 2015;9:54.
Harding IH, Corben LA, Delatycki MB, et al. Cerebral compensation during motor function in Friedreich ataxia: the IMAGE‐FRDA study. Mov Disord 2017;32(8):1221–1229.
Harding IH, Corben LA, Storey E, et al. Fronto‐cerebellar dysfunction and dysconnectivity underlying cognition in friedreich ataxia: the IMAGE‐FRDA study. Hum Brain Mapp 2016;37(1):338–350.
Kerestes R, Cummins H, Georgiou‐Karistianis N, et al. Reduced cerebello‐cerebral functional connectivity correlates with disease severity and impaired white matter integrity in Friedreich ataxia. J Neurol 2023;270(5):2360–2369.
Rezende TJR, Martinez ARM, Faber I, et al. Developmental and neurodegenerative damage in Friedreich's ataxia. Eur J Neurol 2019;26(3):483–489.
Selvadurai LP, Harding IH, Corben LA, et al. Cerebral and cerebellar grey matter atrophy in Friedreich ataxia: the IMAGE‐FRDA study. J Neurol 2016;263(11):2215–2223.
Benkovic SA, Connor JR. Ferritin, transferrin, and iron in selected regions of the adult and aged rat brain. J Comp Neurol 1993;338(1):97–113.
Corben LA, Kashuk SR, Akhlaghi H, et al. Myelin paucity of the superior cerebellar peduncle in individuals with Friedreich ataxia: an MRI magnetization transfer imaging study. J Neurol Sci 2014;343(1–2):138–143.
Thomsen MS, Andersen MV, Christoffersen PR, Jensen MD, Lichota J, Moos T. Neurodegeneration with inflammation is accompanied by accumulation of iron and ferritin in microglia and neurons. Neurobiol Dis 2015;81:108–118.
Holland R, McIntosh AL, Finucane OM, et al. Inflammatory microglia are glycolytic and iron retentive and typify the microglia in APP/PS1 mice. Brain Behav Immun 2018;68:183–196.